243PGermline mutation status and therapy response in patients with triple-negative breast cancer (TNBC): Results of the GeparOcto study. (23rd October 2018)

Record Type:: Journal Article
Title:: 243PGermline mutation status and therapy response in patients with triple-negative breast cancer (TNBC): Results of the GeparOcto study. (23rd October 2018)
Main Title:: 243PGermline mutation status and therapy response in patients with triple-negative breast cancer (TNBC): Results of the GeparOcto study
Authors:: Pohl, E
Schneeweiss, A
Hauke, J
Moebus, V
Furlanetto, J
Denkert, C
Fasching, P A
Hanusch, C
Tesch, H
Weber-Lassalle, N
Müller, V
Rhiem, K
Untch, M
Luebbe, K
Lederer, B
Jackisch, C
Nekljudova, V
Schmutzler, R K
Hahnen, E
Loibl, S
Abstract:
Is Part Of:: Annals of oncology. Volume 29(2018)Supplement 8
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Issue Display:: Volume 29, Issue 8 (2018)
Year:: 2018
Volume:: 29
Issue:: 8
Issue Sort Value:: 2018-0029-0008-0000
Page Start:
Page End:
Publication Date:: 2018-10-23
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdy270.238 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12268.xml